When is a kidney biopsy indicated during the treatment of brain cancer?
Introduction: Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) and is widely used in oncology for its anti-angiogenic properties. However, VEGF inhibition may result in significant nephrotoxicity, including thrombotic microangiopathy (TMA). While systemic T...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SMC MEDIA SRL
2025-08-01
|
| coleção: | European Journal of Case Reports in Internal Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.ejcrim.com/index.php/EJCRIM/article/view/5565 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|